Biological
Rabivax-S
Rabivax-S is a biological therapy with 5 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
2(40%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
40%
Ph phase_4
3
60%
Phase Distribution
0
Early Stage
2
Mid Stage
3
Late Stage
Phase Distribution5 total trials
Phase 2Efficacy & side effects
2(40.0%)
Phase 4Post-market surveillance
3(60.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
2
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(3)
Detailed Status
Completed3
Recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 22 (40.0%)
Phase 43 (60.0%)
Trials by Status
recruiting120%
active_not_recruiting120%
completed360%
Recent Activity
2 active trials
Showing 5 of 5
active_not_recruitingphase_2
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M
NCT07183371
recruitingphase_2
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults
NCT07147400
completedphase_4
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
NCT05937113
completedphase_4
Non-specific Effects of Rabies Vaccine
NCT03656198
completedphase_4
Safety of Rabivax-S for Pre-exposure Prophylaxis
NCT03741270
Clinical Trials (5)
Showing 5 of 5 trials
NCT07183371Phase 2
A Study to Assess the Experimental Malaria Vaccines R78C and RH5.1 With Matrix-M in Combination With R21/Matrix-M
NCT07147400Phase 2
Pfs230D1 + R21 in Matrix-M1 in African School Children and Adults
NCT05937113Phase 4
Safety and Immunogenicity of the Inactivated Rabies Vaccine RABIVAX-S Administered Intramuscularly and Intradermally
NCT03656198Phase 4
Non-specific Effects of Rabies Vaccine
NCT03741270Phase 4
Safety of Rabivax-S for Pre-exposure Prophylaxis
All 5 trials loaded
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 5